Skip to Main Content
An official website of the United States government

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
681-700 of 1651
Name Principal Investigator Institution Study Date Approved Project ID
Exploring the latent space of integrated heterogeneous data sources in breast cancer David Longo Emergent Dynamics PLCO May 12, 2020 PLCO-623
Young adulthood adiposity, weight change, and other metabolic comorbidities with the risk of hepatobiliary cancer incidence and mortality in the PLCO study Xuehong Zhang The Brigham and Women's Hospital, Inc. PLCO Apr 30, 2020 PLCO-618
Studying the role of Clonal Hematopoiesis of Indeterminate Potential in disease progression from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Irene Ghobrial Dana-Farber Cancer Institute PLCO Apr 29, 2020 2019-1020
COVID: Using environmental data and modelling to test the hypothesis that spatial and seasonal patterns in vitamin D deficiency are associated with hospitalizations and mortality due to COVID-19 Elizabeth North University of Maryland Center for Environmental Science PLCO Apr 24, 2020 PLCO-617
The "MetaboMap" project Steven Moore NCI PLCO Apr 23, 2020 PLCO-615
Development of a Novel Prognostic Model for Predicting Metastasis using CNN method in Colorectal Cancer Min Seob Kwak Kyung Hee university at Gangdong PLCO Apr 16, 2020 PLCOI-607
ProstAId-CDS - A Clinical Decision Support System for Prostate Cancer Treatment Stefan Bonn University Medical Center Hamburg Eppendorf / ZMNH PLCO Mar 27, 2020 PLCOI-589
Estimating the probability of overdiagnosis in PLCO trial Jian-Lun Xu NCI PLCO Mar 25, 2020 PLCO-600
Master Degree on Prostate Cancer Survival Katarzyna Adamska Warsaw School of Economics PLCO Mar 20, 2020 PLCO-596
Biomarkers of Exposure and Response to Coffee Intake Erikka Loftfield National Cancer Institute PLCO Mar 20, 2020 PLCO-599
Early Diagnosis of Asthma, Thyroid Cancer and Schizophrenia Diseases Using Computational Intelligence Techniques Sarah Alotaibi IAU PLCO Mar 20, 2020 PLCO-603
EEMS Methods Study Work Erikka Loftfield National Cancer Institute PLCO Mar 18, 2020 2020-9001
Aspirin use and risk of hepatocellular carcinoma incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Holli Loomans-Kropp National Cancer Institute PLCO Mar 18, 2020 PLCO-601
Dietary inflammatory potential and risk of liver cancer in the PLCO study Xuehong Zhang The Brigham and Women’s Hospital, Inc. PLCO Mar 16, 2020 PLCO-598
A Machine Learning Approach to Bladder Cancer Screening and Cancer Grade/Stage Differentiation Herbert Chase The Trustees of Columbia University in the City of New York PLCO Mar 16, 2020 PLCO-597
Association of colorectal polyps with dietary inflammation during screening colonoscopy in Men and Women Bhaumik Brahmbhatt Mayo Clinic PLCO Mar 16, 2020 PLCO-593
Risk Prediction Model for Endometrial Cancer using multiple Machine Learning Algorithms and Meta-Analysis Denis Mihaies Brunel Univeristy PLCO Mar 16, 2020 PLCO-590
Interpretable Artificial Intelligence to select patients that will benefit from lung cancer screening Jean-Emmanuel Bibault Stanford University PLCO Mar 5, 2020 PLCO-594
Personalizing colorectal treatment strategies through machine learning Jean-Emmanuel Bibault Stanford University PLCO Feb 27, 2020 PLCO-592
Treatment effect on the Survival Time of Lung Cancer Patients Jing Zhou Department of Family and Preventive Medicine PLCO Feb 27, 2020 PLCO-591